T-2 mycotoxin

T-2 mycotoxin is a trichothecene mycotoxin. It is a naturally occurring mold byproduct of Fusarium spp. fungus which is toxic to humans and animals. The clinical condition it causes is alimentary toxic aleukia and a host of symptoms related to organs as diverse as the skin, airway, and stomach. Ingestion may come from consumption of moldy whole grains. T-2 can be absorbed through human skin.[2] Although no significant systemic effects are expected after dermal contact in normal agricultural or residential environments, local skin effects can not be excluded. Hence, skin contact with T-2 should be limited.

T-2[1]
Names
IUPAC name
(2α,3α,4β,8α)-4,15-bis(acetyloxy)-3-hydroxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate
Other names
T-2 Toxin
Fusariotoxin T 2
Insariotoxin
Mycotoxin T 2
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.040.255
RTECS number
  • YD0100000
UNII
  • InChI=1S/C24H34O9/c1-12(2)7-18(27)32-16-9-23(10-29-14(4)25)17(8-13(16)3)33-21-19(28)20(31-15(5)26)22(23,6)24(21)11-30-24/h8,12,16-17,19-21,28H,7,9-11H2,1-6H3/t16-,17+,19+,20+,21+,22+,23+,24-/m0/s1 checkY
    Key: BXFOFFBJRFZBQZ-QYWOHJEZSA-N checkY
  • InChI=1/C24H34O9/c1-12(2)7-18(27)32-16-9-23(10-29-14(4)25)17(8-13(16)3)33-21-19(28)20(31-15(5)26)22(23,6)24(21)11-30-24/h8,12,16-17,19-21,28H,7,9-11H2,1-6H3/t16-,17+,19+,20+,21+,22+,23+,24-/m0/s1
    Key: BXFOFFBJRFZBQZ-QYWOHJEZBH
  • O=C(O[C@@H]4C(=C/[C@H]3O[C@H]2[C@]1(OC1)[C@]([C@H](OC(=O)C)[C@H]2O)([C@@]3(COC(=O)C)C4)C)\C)CC(C)C
Properties
C24H34O9
Molar mass 466.527 g·mol−1
Insoluble
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

History

Alimentary toxic aleukia (ATA), a disease which is caused by trichothecenes like T-2 mycotoxin, killed many thousands of USSR citizens in the Orenburg District in the 1940s. It was reported that the mortality rate was 10% of the entire population in that area. During the 1970s it was proposed that the consumption of contaminated food was the cause of this mass poisoning. Because of World War II, harvesting of grains was delayed and food was scarce in Russia. This resulted in the consumption of grain that was contaminated with Fusarium molds, which produce T-2 mycotoxin.[3]

In 1981, the United States Secretary of State Alexander Haig and his successor George P. Shultz accused the Soviet Union of using T-2 mycotoxin as a chemical weapon known as "yellow rain" in Laos (1975–81), Kampuchea (1979–81), and Afghanistan (1979–81), where it allegedly caused thousands of casualties.[4] Although several US chemical weapons experts claim to have identified "yellow rain" samples from Laos as trichothecenes, other experts believe that this exposure was due to naturally occurring T-2 mycotoxin in contaminated foods.[5] Another alternative theory was developed by Harvard biologist Matthew Meselson, who proposed that the "yellow rain" found in Southeast Asia originated from the excrement of jungle bees.[6] The first indication for this theory came from finding high levels of pollen in the collected samples, giving the substance its yellow color. It was also found that jungle bees in this area fly collectively in great numbers, at altitudes too high to be easily seen, producing showers of feces that could have been mistaken for sprays from aircraft.[7] Further testing later determined that the oily liquid was, in fact, the pollen-filled feces of jungle bees.[8] A similar case in China was brought to light, and in this instance the cause of the phenomenon had also been bee excrement.[9] Despite this conclusive analysis, the United States has not withdrawn its allegations and declares that the issue has not been fully resolved.

T-2 mycotoxin is also thought to be a cause of Gulf War Syndrome. US troops suffered from mycotoxicosis-like symptoms after an Iraqi missile detonated in a US military camp in Saudi Arabia during Operation Desert Storm in the Persian Gulf War, in 1991. It has been shown that Iraq researched trichothecene mycotoxins, among other substances, and thus was capable of its possession and employment in chemical warfare. Nevertheless, much of the key information from these incidents remains classified, leaving these matters still unresolved.[10]

Chemical properties

This compound has a tetracyclic sesquiterpenoid 12,13-epoxytrichothene ring system, which relates it to the trichothecenes.[11] These compounds are generally very stable and are not degraded during storage/milling and cooking/processing of food. They do not degrade at high temperatures either. This compound has an epoxide ring, and several acetyl and hydroxyl groups on its side chains. These features are mainly responsible for the biological activity of the compound and make it highly toxic. T-2 mycotoxin is able to inhibit DNA and RNA synthesis in vivo and in vitro[12] and can induce apoptosis.[13] However, in vivo the compound rapidly metabolizes to HT-2 mycotoxin (a major metabolite).[14]

Mechanism of action

The toxicity of T-2 toxin is due to its 12,13-epoxy ring.[15] Epoxides are in general toxic compounds; these react with nucleophiles and then undergo further enzymatic reactions. The reactivity of epoxides can lead to reactions with endogenous compounds and cellular constituents like DNA bases and proteins.[16] These reactions could be the reason for the noticed actions and effects of T-2 mycotoxin. The toxic compound influences the metabolism of membrane phospholipids, leads to an increase of liver lipid peroxidases and has an inhibiting effect on DNA and RNA synthesis. In addition it can bind to an integral part of the 60s ribosomal subunit, peptidyltransferase, thereby inhibiting protein synthesis. These effects are thought to be the explanation for T-2 toxin inducing apoptosis (cell death) in different tissues as the immune system, the gastrointestinal tissue and also fetal tissue. With regard to apoptosis there has been noticed that the level of the pro-apoptotic factor Bas (Bcl-2-associated X protein) was increased and the level of Bcl-xl, an anti-apoptotic factor, was decreased in human chrondocytes (cartilage cells). When exposed to T-2 mycotoxin. Furthermore, the level of Fas, an apoptosis-related cell-surface antigen and p53, a protein regulating the cell cycle, were increased.

Simplified biosynthesis of the T-2 Mycotoxin in F. sporotrichioides

Synthesis

T-2 mycotoxin is produced naturally by Fusarium fungi of which the most important species are: F. sporotrichioides, F. langsethiae, F. acuminatum and F. poae. These fungi are found in grains such as barley, wheat and oats. The production of this compound for research and commercial purposes is generally accomplished by cultivating some strain of T-2 mycotoxin producing fungi on agar plates. On these agar plates the fungi appear powdery and can yield substantial amounts of T-2 mycotoxin. For the isolation of the compound high pressure liquid chromatography is commonly used (HPLC).[17]

In the Fusarium species, biosynthesis of the T-2 mycotoxin often starts with trichodiene, and many of the species share a common route of oxidizations and cyclizations. As an example, from the F. sporotrichioides species, the important oxidation steps that occur start from trichodiene and goes to isotrichodiol. From there, the eleventh carbon atom is oxidized to form isotrichotriol. The ninth carbon is then oxidized, and trichotriol is formed, which then cyclizes to make isotrichodermol. After that, the fifteenth carbon is oxidized to form didecalonectrin, which leads to the fourth carbon being oxidized, and diacetoxyscirpenol is formed. The second to last step is the oxidation of the eighth carbon to make neosolaniol, which then undergoes slight modification to create the T-2 toxin.[18]

Toxicity

Absorption & Exposure

Humans and animals are generally exposed to T-2 mycotoxins through food. Certain grains can contain the toxin which makes it a threat to human health and an economic burden.[19] Unlike most biological toxins T-2 mycotoxin can be absorbed through intact skin. The compound can be delivered via food, water, droplets, aerosols and smoke from various dispersal systems. This makes it a potential biological weapon, however large amounts of the compound are required for a lethal dose. T-2 mycotoxin has an LD50 of approximately 1 milligram per kilogram of body weight.

The EFSA estimates that the mean exposure of T-2 in the EU lies between 12 and 43 ng/kg bw/day.[20] This range is below the TDI of 100 ng/ kg body weight for the sum of HT-2 and T-2 toxins which is used by the EFSA.

Distribution

T-2 mycotoxin is distributed uniformly throughout the body without preference to a specific organ or site. In rodents, plasma concentration levels peak around roughly thirty minutes after exposure, and in one study, the half-life of the T-2 toxin was seen to be less than twenty minutes. In a different study involving pigs, the distribution after four hours of IV injection was seen to be 15-24% in the GI tract and 4.7-5.2% in various other tissues.[21]

Metabolism

Once absorbed and distributed to various tissues, the T-2 mycotoxin goes through various metabolic reactions before it gets excreted. In vivo studies showed that the most occurring reactions are ester hydrolysis and hydroxylation of the isovaleryl group. Deepoxidation and glucuronide conjugation do also occur. Ht-2 is the main metabolite. For the hydroxylation, the cytochrome p450 enzyme complex is suggested to be involved. T-2 triol and T-2 tetraol are most likely to be formed via acetylcholine esterases. Some of the metabolic reactions of the mycotoxin are performed by the microflora in the gut. The formed metabolites in these reactions are species- and pH-dependent. The ester cleavages are however performed by the mammal itself and not by the microflora. In red blood cells T-2 mycotoxin is metabolized to neosolaniol, and, in white blood cells, to HT-2 via hydrolysis catalyzed by carboxylesterases.

Excretion

Following absorption, distribution, and metabolism, T-2 mycotoxin is excreted fairly quickly, where 80-90% of it is excreted within 48 hours.[21] The main methods of excretion seem to be from the urine and feces,[22] where excretion through bile contributes heavily to the feces route of excretion.[15] There is also very little of the parent T-2 mycotoxin in the excretions, meaning most of the initial compound is metabolized beforehand.[22]

Toxic effects

T-2 is highly toxic when inhaled. Acute toxic symptoms include vomiting, diarrhea, skin irritation, itching, rash, blisters, bleeding and dyspnea.[23] If the individual is exposed to T-2 over a longer period alimentary toxic aleukia (ATA) develops.

At first the patient experiences a burning sensation in the mouth, throat and stomach. After a few days the person will suffer from an acute gastroenteritis that will last for 3 to 9 days. Within 9 weeks the bone marrow will slowly degenerate. Also the skin starts bleeding and the total number of leukocytes decreases. Problems with the nervous system can occur.

In the end the following symptoms might occur: a high fever, petechial haemorrhage, necrosis of muscles and skin, bacterial infections of the necrotic tissue, enlarged lymph nodes. There is the possibility of asphyxiation because of laryngeal oedema and stenosis of the glottis. The lack of oxygen is then the cause of death. Otherwise the patient will die of bronchial pneumonia and lung bleeding.[24]

Effects on animals

T-2 mycotoxin is also toxic to animals. The compound is known for having lethal and sub-lethal effects on farm animals. It is often found in contaminated cereal grains that are fed to these animals.[25] Most of the toxic effects are shared between humans and animals. After exposing zebra fish embryos to a concentration of 20 μmol/L or higher malformation and mortality rates increased. The malformations included tail deformities, cardiovascular defects and changes in behavior in early stages of life. This is the result of an increase in the amount of epoxides, which causes cell apoptosis.[26] Other studies have shown that T-2-toxin causes lipid peroxidation in rats after feeding it to them. As the effect of T-2 toxin, elevated reactive oxygen species (ROS) levels were observed in several mammalian species. However, in spite of the general harmful effects caused by the toxin, in a study carried out in different chicken derived hepatic cell culture models, no alterations were found in the redox status of the cells.[27]

The compound also seems to reduce the fertility of ewes and heifers. Research has shown that a high dose of T-2 delays the ovulation due to a delayed follicle maturation. This possibly retards the following luteinisation, which makes it impossible for female animals to conceive.

T-2 also has an effect on the fertility of bulls. In 1998 it was discovered that moldy hay influenced the quality of semen of bulls. Analysis of the moldy hay showed that T-2 was present. The compound decreased sperm motility and testosterone levels and increased the frequency of morphological abnormalities in the sperm cells.

The liver is another target for the mycotoxin. It is one of the first organs where the compound passes through after ingestion. Here it causes a reduced expression of CYP1A proteins in rabbits, pigs and rats. CYP3A activity decreases in pigs too. These enzymes help metabolize drugs that pass through the liver. Decrease in the activity could lead to an increase of unmetabolized drugs in the plasma. This can have a dangerous effect on an animal's health.[28]

All of the mentioned effects happen when T-2 is ingested in high doses. Animals are able to metabolize the compound with enzymes from the CYP3A family, just like humans.

Treatments

At the moment, there is no specific therapy for T-2 mycotoxin poisonings.[22] Exposure of the mycotoxin is typically followed by standardized treatment for toxic compounds in order to reduce the effect of the toxin. This includes using activated charcoal, which has a high binding capacity of 0.48 mg of T-2 mycotoxin to 1 mg of charcoal.[22] For dermal contact, soap and water is used to reduce the dermal effects.[22] As a kind of prophylaxis, antioxidants are believed to have properties that may provide benefits.[21]

Application

There are currently no applications, aside from war, for T-2 mycotoxins; however, there are some plausible therapeutic uses. Due to their abilities, research shows possible uses for the mycotoxin as growth promoters, antibiotics, antivirals, as an antileukemic, and as an antimalarial.[21]

See also

References
  1. T-2 Toxin: essential data Archived October 12, 2008, at the Wayback Machine
  2. Boonen, Jente; Malysheva, Svetlana V.; Taevernier, Lien; Diana Di Mavungu, José; De Saeger, Sarah; De Spiegeleer, Bart (2012). "Human skin penetration of selected model mycotoxins". Toxicology. 301 (1–3): 21–32. doi:10.1016/j.tox.2012.06.012. PMID 22749975.
  3. Pitt, J. L., An introduction to mycotoxins. In Mycotoxin prevention and control in foodgrains, 1989.
  4. Shultz, G. P. Chemical warfare in Southeast Asia and Afghanistan: an update; The United States Secretary Of State: Washington, D.C., 1982.
  5. Caldwell, R.D. (1983). "'Yellow rain' or natural toxins?". Nature. 301 (5902): 651. Bibcode:1983Natur.301Q.651C. doi:10.1038/301651a0. S2CID 4263047.
  6. Yellow Rain Falls. The New York Times 3 September 1987.
  7. Meselson, Matthew S.; Robinson, Julian Perry (June 2008). "The Yellow Rain Affair: Lessons from a Discredited Allegation". In Clunan, Anne L.; Lavoy, Peter R.; Martin, Susan B. (eds.). Terrorism, War, or Disease? Unraveling the Use of Biological Weapons. Stanford: Stanford University Press. pp. 72–96. Archived from the original on 2014-07-27. Retrieved 2015-09-03.
  8. "Yellow Rain Falls". New York Times. September 3, 1987. Archived from the original on November 9, 2012. Retrieved January 20, 2022. Yellow rain is the excrement of jungle bees. It's yellow from digested pollen grains, and it rains down from swarms of bees too high to be seen. His theory turns out to be exactly right. The Government's own studies, still unpublished, prove that the source is bees, not bombs.
  9. Zhang, Zhongying (1977). "A Study of the Origin and the Pollen Analysis of "Yellow Rain" in Northern Jiangsu". Kexue Tongbao. 22: 409–12.
  10. Zilinskas, Raymond A. (1997). "Iraq's Biological Weapons: The past as future?". JAMA. 278 (5): 418–24. doi:10.1001/jama.1997.03550050080037. PMID 9244334.
  11. CBRNE - T-2 Mycotoxins at eMedicine
  12. Marin, S.; Ramos, A. J.; Cano-Sancho, G.; Sanchis, V., Mycotoxins: Occurrence, toxicology, and exposure assessment. Food and Chemical Toxicology 2013, 60 (0), 218-237
  13. Torp, M.; Langseth, W., Production of T-2 toxin by a Fusarium resembling Fusarium poae. Mycopathologia 1999, 147 (2), 89-96.
  14. Wu, Q. H.; Wang, X.; Yang, W.; Nussler, A. K.; Xiong, L. Y.; Kuca, K.; Dohnal, V.; Zhang, X. J.; Yuan, Z. H., Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: an update. Archives of toxicology 2014, 88 (7), 1309-26.
  15. Li, Y.; Wang, Z.; Beier, R. C.; Shen, J.; De Smet, D.; De Saeger, S.; Zhang, S., T-2 toxin, a trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods. Journal of agricultural and food chemistry 2011, 59 (8), 3441-53.
  16. John A. Timbrell, Principles of Biochemical Toxicologie. CRC Press: 2009; Vol. 8.
  17. T-2 toxin from fusarium sp., powder, ≥98% (HPLC). http://www.sigmaaldrich.com/catalog/product/sigma/t4887?lang=en&region=NL (accessed 25 march).
  18. Desjardins, AE; Hohn, TM; McCormick, SP (September 1993). "Trichothecene biosynthesis in Fusarium species: chemistry, genetics, and significance". Microbiological Reviews. 57 (3): 595–604. doi:10.1128/MMBR.57.3.595-604.1993. PMC 372927. PMID 8246841.
  19. Wan, Q.; Wu, G.; He, Q.; Tang, H.; Wang, Y., The toxicity of acute exposure to T-2 toxin evaluated by the metabonomics technique. Molecular BioSystems 2015, 11 (3), 882-91.
  20. Escrivá, L.; Font, G.; Manyes, L., In vivo toxicity studies of fusarium mycotoxins in the last decade: A review. Food and Chemical Toxicology 2015, 78 (0), 185-206.
  21. Adhikari, Manish; Negi, Bhawana; Kaushik, Neha; Adhikari, Anupriya; Al-Khedhairy, Abdulaziz A.; Kaushik, Nagendra Kumar; Choi, Eun Ha (16 February 2017). "T-2 mycotoxin: toxicological effects and decontamination strategies". Oncotarget. 8 (20): 33933–33952. doi:10.18632/oncotarget.15422. PMC 5464924. PMID 28430618.
  22. Wannemacher, Robert W.; Weiner, Stanley L. (1997). Medical aspects of chemical and biological warfare: Ch 34 Trichothecene Mycotoxins. U S Govt. Printing Office. pp. 655–676. ISBN 9789997320919.
  23. Kalantari H, M. M., REVIEW ON T-2 TOXIN. Jundishapur Journal of Natural Pharmaceutical Products 2010, 5 (1), 26-38.
  24. R.L. Semple, A. S. F., P.A. Hicks and J.V. Lozare, Mycotoxin prevention and control in foodgrains. UNDP/FAO Regional Network Inter-Country Cooperation on Preharvest Technology and Quality Control of Foodgrains (REGNET) and the ASEAN Grain Postharvest Programme: Thailand, 1989.
  25. Cortinovis, C.; Pizzo, F.; Spicer, L. J.; Caloni, F., Fusarium mycotoxins: effects on reproductive function in domestic animals--a review. Theriogenology 2013, 80 (6), 557-64.
  26. Yuan, G.; Wang, Y.; Yuan, X.; Zhang, T.; Zhao, J.; Huang, L.; Peng, S., T-2 toxin induces developmental toxicity and apoptosis in zebrafish embryos. Journal of environmental sciences 2014, 26 (4), 917-25.
  27. Mackei, M.; Orbán, K.; Molnár, A.; Pál, L.; Dublecz, K.; Husvéth, F.; Neogrády, Z.; Mátis, G. Cellular Effects of T-2 Toxin on Primary Hepatic Cell Culture Models of Chickens. Toxins 2020, 12, 46. https://doi.org/10.3390/toxins12010046
  28. Goossens, J.; De Bock, L.; Osselaere, A.; Verbrugghe, E.; Devreese, M.; Boussery, K.; Van Bocxlaer, J.; De Backer, P.; Croubels, S., The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs. Food and Chemical Toxicology 2013, 57, 54-6.
  • Bamburg, J.R., Riggs, N.V. and Strong, F.M. "The structure of toxins from two stains of Fusarium tricinctum." Tetrahedron 24, 3329-3336 (1968).
  • Bamburg, J.R. and Strong, F.M. "12, 13-Epoxytrichothecenes." In "Microbial Toxins," VII S. Kadis, A. Ciegler and S.J. Ajl (Eds.) Academic Press, New York, NY, pp. 207–292 (1971).

Further reading
  • USAMRIID's Medical Management Of Biological Casualties Handbook
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.